Patents Represented by Attorney Francis J. Tinney
  • Patent number: 4996201
    Abstract: 4-(N-Substituted amino)-2-butynyl-1-carbamates and thiocarbamates and derivatives thereof are described, as well as methods for the preparation and pharmaceutical compositions of same, which are useful as centrally acting muscarinic agents and are useful as analgesic agents for the treatment of pain, as sleep aids and as agents for treating the symptoms of senile dementia, Alzheimer's disease, Huntington's chorea, tardive dyskinesia, hyperkinesia, mania, or similar conditions of cerebral insufficiency characterized by decreased cerebral acetylcholine production or release.
    Type: Grant
    Filed: August 2, 1989
    Date of Patent: February 26, 1991
    Assignee: Warner-Lambert Co.
    Inventors: Stephen C. Bergmeier, Jeffrey A. Kester, Walter H. Moos, Haile Tecle, Anthony J. Thomas
  • Patent number: 4988699
    Abstract: Substituted tetrahydrobenzothiazoles are described, as well as methods for the preparation and pharmaceutical composition of same, which are useful as dopamine agonists with selectivity for the presynaptic dopamine receptor and are useful as dopaminergic, antipsychotic, and antihypertensive agents as well as for treating hyperprolactinaemia-related conditions and central nervous system disorders.
    Type: Grant
    Filed: March 14, 1989
    Date of Patent: January 29, 1991
    Assignee: Warner-Lambert Company
    Inventors: Bradley W. Caprathe, Juan C. Jaen, Lawrence D. Wise
  • Patent number: 4988688
    Abstract: 4-(N-Substituted amino)-2-butynyl-1-ureas and thioureas and derivatives thereof are described, as well as methods for the preparation and pharmaceutical compositions of same, which are useful as centrally acting muscarinic agents and are useful as analgesic agents for the treatment of pain, as sleep aids and as agents for treating the symptoms of senile dementia, Alzheimer's disease, Huntington's chorea, tardive dyskinesia, hyperkinesia, mania, or similar conditions of cerebral insufficiency characterized by decreased cerebral acetylcholine production or release.
    Type: Grant
    Filed: August 2, 1989
    Date of Patent: January 29, 1991
    Assignee: Warner-Lambert Company
    Inventors: Jeffrey A. Kester, Walter H. Moos, Anthony J. Thomas
  • Patent number: 4977172
    Abstract: (S)-3-Ethyl-4-[(1-methyl-1H-imidazol-5-yl)-methyl]-2-oxazolidinone or a pharmaceutically acceptable salt thereof is useful in the treatment of the symptoms of cognitive decline in an elderly patient suffering therefrom including the treatment of Alzheimer's disease.
    Type: Grant
    Filed: September 29, 1989
    Date of Patent: December 11, 1990
    Assignee: Warner-Lambert Company
    Inventors: Stephen J. Johnson, Walter H. Moos
  • Patent number: 4977154
    Abstract: Novel 7-piperazine derivatives of 5-amino- and 5-hydroxy-1-cyclopropyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids as antibacterial agents are described as well as methods for their manufacture, formulation, and use in treating bacterial infections.
    Type: Grant
    Filed: October 20, 1986
    Date of Patent: December 11, 1990
    Assignee: Warner-Lambert Company
    Inventors: Joseph P. Sanchez, Ashok K. Trehan
  • Patent number: 4975456
    Abstract: Novel N-(substituted-phenyl)-5-(substituted-2,5-dimethylphenoxy)-2,2- dimethylpentanamides which are useful in preventing the intestinal absorption of cholesterol and also increasing high-density lipoprotein (HDL) cholesterol, as well as novel pharmaceutical compositions and methods of use, as well as processes for their manufacture are herein described.
    Type: Grant
    Filed: July 13, 1989
    Date of Patent: December 4, 1990
    Assignee: Warner-Lambert Company
    Inventors: Paul L. Creger, Milton L. Hoefle, Ann Holmes
  • Patent number: 4975445
    Abstract: Substituted cyclohexenes are described, as well as methods for the preparation and pharmaceutical composition of same, which are useful as central nervous system agents and are particularly useful as dopaminergic, antipsychotic, and antihypertensive agents as well as for treating hyperprolactinaemia-related conditions and central nervous system disorders.
    Type: Grant
    Filed: December 6, 1989
    Date of Patent: December 4, 1990
    Assignee: Warner-Lambert Company
    Inventors: Bradley W. Caprathe, Juan C. Jaen, Sarah J. Smith, Lawrence D. Wise
  • Patent number: 4957921
    Abstract: Substituted cyclohexanols are described, as well as methods for the preparation and pharmaceutical composition of same, which are useful as central nervous system agents and are particularly useful as dopaminergic, antipsychotic, and antihypertensive agents as well as for treating hyperprolactinaemia-related conditions and central nervous system disorders.
    Type: Grant
    Filed: December 6, 1989
    Date of Patent: September 18, 1990
    Assignee: Warner-Lambert Company
    Inventors: Bradley W. Caprathe, Juan C. Jaen, Sarah J. Smith, Lawrence D. Wise
  • Patent number: 4935424
    Abstract: Substituted 2-aminothiazoles are described, as well as methods for the preparation and pharmaceutical compositions of same, which are useful as dopamine agonists with selectivity for the presynaptic dopamine receptor and are useful as dopaminergic, antipsychotic, and antihypertensive agents as well as for treating hyperprolactinaemia-related conditions and central nervous system disorders.
    Type: Grant
    Filed: May 27, 1988
    Date of Patent: June 19, 1990
    Assignee: Warner-Lambert Company
    Inventors: Bradley W. Caprathe, Juan C. Jaen, Lawrence D. Wise
  • Patent number: 4923861
    Abstract: Novel 6-[2-[2-(substituted amino)-3-quinolinyl]-ethenyl and ethyl]tetrahydro-4-hydroxypyran-2-ones and/or oxides and the corresponding dihydroxy ring opened acids and esters are described, as well as methods for the preparation and pharmaceutical compositions of same, which are useful as inhibitors of the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) and are thus useful hypolipidemic and hypocholesterolemic agents.
    Type: Grant
    Filed: February 7, 1989
    Date of Patent: May 8, 1990
    Assignee: Warner-Lambert Company
    Inventors: Joseph A. Picard, Drago R. Sliskovic
  • Patent number: 4923896
    Abstract: Novel N-[substituted aryl]-N'-(substituted alkoxy)-urea and thiourea derivatives are described, as well as methods for the preparation and pharmaceutical composition of same, which are useful in preventing the intestinal absorption of cholesterol and thus are useful in the treatment of hypercholesterolemia and atherosclerosis.
    Type: Grant
    Filed: February 9, 1989
    Date of Patent: May 8, 1990
    Assignee: Warner-Lambert Company
    Inventor: Bharat K. Trivedi
  • Patent number: 4915957
    Abstract: A process for the preparation of an antacid material prepared from magnesium aluminum hydroxide, wherein magnesium hydroxide and/or magnesium oxide is reacted in an atomic ratio of magnesium to aluminum of 1:1 to 3:1 with an aqueous solution of aluminum sulfate until the pH of the reaction mixture is from 4.0 to 8.0, whereafter water-soluble components are removed from the mixture is known manner and this is isolated and, if desired, dried is described as well as a new embodiment of the formula [Mg.sub.5 Al.sub.10 (OH).sub.26 O.sub.5 ](SO.sub.4).sub.2 .multidot.nH.sub.2 O. Also described are pharmaceutical compositions containing such antacid material, in admixture with a conventional pharmaceutical adjuvant, and a method of combating hyperacidity and gastrointestinal diseases, which comprises administering such antacid material.
    Type: Grant
    Filed: August 8, 1984
    Date of Patent: April 10, 1990
    Assignee: Godecke Aktiengesellschaft
    Inventors: Michael Schneider, Adolf Knecht
  • Patent number: 4905866
    Abstract: A device for holding and dispensing pills which enables the dispensing of pills in successive order. Pills are mounted in a compact in a single row in the desired successive order and a pill ejector is arranged for incremental movement in one direction along the compact. When the pill ejector is adjacent to a pill, a bendable member is displaced to push the pill out of a blister type package and through an opening in the rear of the compact.
    Type: Grant
    Filed: November 9, 1987
    Date of Patent: March 6, 1990
    Assignee: Warner-Lambert Company
    Inventors: Ralph Bartell, Frank Neggers
  • Patent number: 4889236
    Abstract: A rigid, tripartite, credit card-style blister-pack medication package is disclosed which is particularly useful for dispensing medications which must be taken on a calendar day schedule. The package is of discrete design and may be conveniently carried in a purse or billfold.
    Type: Grant
    Filed: February 26, 1988
    Date of Patent: December 26, 1989
    Assignee: Warner-Lambert Company
    Inventors: Ralph Bartell, Roger Boissonneault, Monica Blischok
  • Patent number: 4885386
    Abstract: An improved process for the preparation of 3-chloro-2,4,5-trifluorobenzoic acid is described which involves reaction of a diester of 3,4,5,6-tetrafluoro-1,2-benzenedicarboxylic acid with a substituted amine to afford 3-amino-2,4,5-trifluorobenzoic acid followed by subsequent conversion of the amio intermediate into 3-chloro-2,4,5-trifluorobenzoic acid.
    Type: Grant
    Filed: October 28, 1988
    Date of Patent: December 5, 1989
    Assignee: Warner-Lambert Company
    Inventors: James N. Wemple, Gregory L. Karrick, Floyd G. Spence
  • Patent number: 4882357
    Abstract: Novel N-(substituted-phenyl)-5-(substituted-2,5-dimethylphenoxy)-2,2-dimethylpen tan amides which are useful in preventing the intestinal absorption of cholesterol and also increasing high-density lipoprotein (HDL) cholesterol, as well as novel pharmaceutical compositions and methods of use, as well as processes for their manufacture are herein described.
    Type: Grant
    Filed: July 15, 1988
    Date of Patent: November 21, 1989
    Assignee: Warner-Lambert Company
    Inventors: Paul L. Creger, Milton L. Hoefle, Ann Holmes
  • Patent number: 4876343
    Abstract: An improved process for the preparation of statine, the phenyl analog of statine, the cyclohexyl analog of statine and derivatives thereof is described, as well as other valuable intermediates used in the process.
    Type: Grant
    Filed: June 15, 1988
    Date of Patent: October 24, 1989
    Assignee: Warner-Lambert Company
    Inventors: John C. Hodges, Sylvester Klutchko
  • Patent number: 4857530
    Abstract: Novel 6-substituted-4(3H)-quinazolinones are described as well as methods for the preparation and pharmaceutical composition of same, which inhabit the enzyme thymidylate synthase (TS) and are thus useful as anticancer agents.
    Type: Grant
    Filed: November 3, 1987
    Date of Patent: August 15, 1989
    Assignee: Warner-Lambert Company
    Inventors: Ellen M. Berman, Leslie M. Werbel, Dennis J. McNamara
  • Patent number: 4851415
    Abstract: Certain quinolone and naphthyridine antibiotics are useful for treating ocular infections by topical administration.
    Type: Grant
    Filed: June 17, 1987
    Date of Patent: July 25, 1989
    Assignee: Warner-Lambert Company
    Inventors: Thomas F. Mich, Carl L. Heifetz
  • Patent number: 4840956
    Abstract: Disubstituted 7-pyrrolidinoquinoline- and -napthylridine-3-carboxylic acids as antibacterial agents are described as well as methods for their manufacture, formulation, and use in treating bacterial infections.
    Type: Grant
    Filed: January 14, 1988
    Date of Patent: June 20, 1989
    Assignee: Warner-Lambert Company
    Inventors: John M. Domagala, Susan E. Hagen, Joseph P. Sanchez, Marjorie S. Solomon